Clinical Trials List
2026-07-26 - 2029-10-29
Phase III
Not yet recruiting5
-
Trial Applicant
Astellas Pharma Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Chang-Fang Chiu 無
- Yu-Min Liao 無
- Che-Hung Lin 無
- 陳珈妤 無
- 王秀慈 無
- Chi-Ching Chen 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 黃文冠 無
- Yung-Chia Kao 無
- 黃振洋 無
- Jen-Shi Chen 無
- Wen-Chi Shen 無
- 陳建銘 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- YU-YUN SHAO 無
- 莊建淮 無
- Kun-Huei Yeh 無
- Chih-Hung Hsu 無
- 郭弘揚 無
- TSUNG-HAO LIU 無
- 呂理駿 無
- WEI-LI MA 無
- 陳柏邑 無
- Chia-Chi Lin 無
- Hsiang-Fong Kao 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- HUI-WEN LIU 無
- 蔡承志 無
- 莊博雅 無
- Wei-Hong Cheng 無
- 趙袓怡 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Hung-Yuan Yu 無
- Yi-Ping Hung 無
- 李癸汌 無
- 唐振育 無
- Shao-Jung Hsu 無
- 姜乃榕 無
- Ming-Huang Chen 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
614 participants
